EP1529775A1 - Verfahren zur Herstellung von Chelaten von Metallen mit organischen Säuren - Google Patents
Verfahren zur Herstellung von Chelaten von Metallen mit organischen Säuren Download PDFInfo
- Publication number
- EP1529775A1 EP1529775A1 EP03257013A EP03257013A EP1529775A1 EP 1529775 A1 EP1529775 A1 EP 1529775A1 EP 03257013 A EP03257013 A EP 03257013A EP 03257013 A EP03257013 A EP 03257013A EP 1529775 A1 EP1529775 A1 EP 1529775A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- metal
- organic acid
- hydroxide
- group
- chelate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000007524 organic acids Chemical class 0.000 title claims abstract description 49
- 238000000034 method Methods 0.000 title claims abstract description 23
- 229910052751 metal Inorganic materials 0.000 title claims description 38
- 239000002184 metal Substances 0.000 title claims description 38
- 238000002360 preparation method Methods 0.000 title description 2
- 239000013522 chelant Substances 0.000 claims abstract description 20
- 239000003446 ligand Substances 0.000 claims abstract description 20
- 150000002736 metal compounds Chemical class 0.000 claims abstract description 19
- 238000001914 filtration Methods 0.000 claims abstract description 8
- 238000001704 evaporation Methods 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 89
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 30
- 239000007788 liquid Substances 0.000 claims description 28
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 15
- 239000000725 suspension Substances 0.000 claims description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 10
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 claims description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 229910021503 Cobalt(II) hydroxide Inorganic materials 0.000 claims description 8
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 claims description 8
- 239000005750 Copper hydroxide Substances 0.000 claims description 8
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 8
- 239000004471 Glycine Substances 0.000 claims description 8
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 8
- 239000004472 Lysine Substances 0.000 claims description 8
- 239000000292 calcium oxide Substances 0.000 claims description 8
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 8
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 claims description 8
- ASKVAEGIVYSGNY-UHFFFAOYSA-L cobalt(ii) hydroxide Chemical compound [OH-].[OH-].[Co+2] ASKVAEGIVYSGNY-UHFFFAOYSA-L 0.000 claims description 8
- 229910001956 copper hydroxide Inorganic materials 0.000 claims description 8
- 235000013922 glutamic acid Nutrition 0.000 claims description 8
- 239000004220 glutamic acid Substances 0.000 claims description 8
- NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical compound [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 claims description 8
- 239000000395 magnesium oxide Substances 0.000 claims description 8
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 8
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims description 8
- IPJKJLXEVHOKSE-UHFFFAOYSA-L manganese dihydroxide Chemical compound [OH-].[OH-].[Mn+2] IPJKJLXEVHOKSE-UHFFFAOYSA-L 0.000 claims description 8
- 229910000000 metal hydroxide Inorganic materials 0.000 claims description 8
- 229910044991 metal oxide Inorganic materials 0.000 claims description 8
- 150000004706 metal oxides Chemical class 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- UGZADUVQMDAIAO-UHFFFAOYSA-L zinc hydroxide Chemical compound [OH-].[OH-].[Zn+2] UGZADUVQMDAIAO-UHFFFAOYSA-L 0.000 claims description 8
- 229910021511 zinc hydroxide Inorganic materials 0.000 claims description 8
- 229940007718 zinc hydroxide Drugs 0.000 claims description 8
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims description 7
- 150000004692 metal hydroxides Chemical class 0.000 claims description 7
- 229910021555 Chromium Chloride Inorganic materials 0.000 claims description 6
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 claims description 6
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 claims description 6
- 229940099596 manganese sulfate Drugs 0.000 claims description 6
- 239000011702 manganese sulphate Substances 0.000 claims description 6
- 235000007079 manganese sulphate Nutrition 0.000 claims description 6
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 6
- 235000001968 nicotinic acid Nutrition 0.000 claims description 6
- 108010016626 Dipeptides Proteins 0.000 claims description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 5
- 239000011664 nicotinic acid Substances 0.000 claims description 5
- 229960003512 nicotinic acid Drugs 0.000 claims description 5
- 239000003208 petroleum Substances 0.000 claims description 5
- 229920001184 polypeptide Polymers 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 5
- 235000018102 proteins Nutrition 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 4
- 239000011668 ascorbic acid Substances 0.000 claims description 4
- 229960005070 ascorbic acid Drugs 0.000 claims description 4
- 235000010323 ascorbic acid Nutrition 0.000 claims description 4
- 229960004106 citric acid Drugs 0.000 claims description 4
- 239000011790 ferrous sulphate Substances 0.000 claims description 4
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 4
- 229960002449 glycine Drugs 0.000 claims description 4
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 4
- 229910021506 iron(II) hydroxide Inorganic materials 0.000 claims description 4
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 4
- 229960003646 lysine Drugs 0.000 claims description 4
- 229940081066 picolinic acid Drugs 0.000 claims description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 3
- 229960002989 glutamic acid Drugs 0.000 claims 3
- 238000010438 heat treatment Methods 0.000 claims 1
- 230000008020 evaporation Effects 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- 239000000203 mixture Substances 0.000 description 20
- 238000010992 reflux Methods 0.000 description 16
- 239000000843 powder Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 9
- 239000011575 calcium Substances 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 7
- 239000011777 magnesium Substances 0.000 description 6
- LUMVCLJFHCTMCV-UHFFFAOYSA-M potassium;hydroxide;hydrate Chemical compound O.[OH-].[K+] LUMVCLJFHCTMCV-UHFFFAOYSA-M 0.000 description 6
- 239000012429 reaction media Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 239000011651 chromium Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000011572 manganese Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 235000014413 iron hydroxide Nutrition 0.000 description 4
- 229910021645 metal ion Inorganic materials 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 235000002538 magnesium citrate Nutrition 0.000 description 3
- 238000003801 milling Methods 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- XXDVUVPHJGZWQC-QHTZZOMLSA-L (2s)-2-amino-5-hydroxy-5-oxopentanoate;iron(2+) Chemical compound [Fe+2].[O-]C(=O)[C@@H](N)CCC(O)=O.[O-]C(=O)[C@@H](N)CCC(O)=O XXDVUVPHJGZWQC-QHTZZOMLSA-L 0.000 description 2
- CFSIMSPVBRMSRX-DFWYDOINSA-L (2s)-2-aminopentanedioate;manganese(2+) Chemical compound [Mn+2].[O-]C(=O)[C@@H](N)CCC([O-])=O CFSIMSPVBRMSRX-DFWYDOINSA-L 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000001354 calcium citrate Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 150000004679 hydroxides Chemical class 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- XBDUTCVQJHJTQZ-UHFFFAOYSA-L iron(2+) sulfate monohydrate Chemical compound O.[Fe+2].[O-]S([O-])(=O)=O XBDUTCVQJHJTQZ-UHFFFAOYSA-L 0.000 description 2
- 229960005336 magnesium citrate Drugs 0.000 description 2
- 239000004337 magnesium citrate Substances 0.000 description 2
- 229940004916 magnesium glycinate Drugs 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- -1 picolinic Chemical class 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 235000013337 tricalcium citrate Nutrition 0.000 description 2
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical class [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- PMZXRGNEHVXGEU-DFWYDOINSA-N (2S)-2-aminopentanedioyl dichloride chromium Chemical compound [Cr].N[C@@H](CCC(Cl)=O)C(Cl)=O PMZXRGNEHVXGEU-DFWYDOINSA-N 0.000 description 1
- IXONOEXDSRFORV-UHFFFAOYSA-N 2-aminoacetic acid;cobalt Chemical compound [Co].NCC(O)=O.NCC(O)=O IXONOEXDSRFORV-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VCXNBTGQKMAQFL-QTNFYWBSSA-J S(=O)(=O)([O-])[O-].N[C@@H](CCC(=O)[O-])C(=O)[O-].[Mn+4] Chemical compound S(=O)(=O)([O-])[O-].N[C@@H](CCC(=O)[O-])C(=O)[O-].[Mn+4] VCXNBTGQKMAQFL-QTNFYWBSSA-J 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- DYVKGOVCCLREIY-UHFFFAOYSA-N azanium;pyridine-2-carboxylate Chemical compound [NH4+].[O-]C(=O)C1=CC=CC=N1 DYVKGOVCCLREIY-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 235000011001 calcium citrates Nutrition 0.000 description 1
- IFJWCHSJEZRVMN-MDTVQASCSA-L calcium;(2s)-2,6-diaminohexanoate Chemical compound [Ca+2].NCCCC[C@H](N)C([O-])=O.NCCCC[C@H](N)C([O-])=O IFJWCHSJEZRVMN-MDTVQASCSA-L 0.000 description 1
- OFNJDDJDXNMTHZ-UHFFFAOYSA-L calcium;2-aminoacetate Chemical compound [Ca+2].NCC([O-])=O.NCC([O-])=O OFNJDDJDXNMTHZ-UHFFFAOYSA-L 0.000 description 1
- JYYOBHFYCIDXHH-UHFFFAOYSA-N carbonic acid;hydrate Chemical compound O.OC(O)=O JYYOBHFYCIDXHH-UHFFFAOYSA-N 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- FFRCYLXQILHVNV-BBDGQJMTSA-K chromium(3+);(2s)-2,6-diaminohexanoate Chemical compound [Cr+3].NCCCC[C@H](N)C([O-])=O.NCCCC[C@H](N)C([O-])=O.NCCCC[C@H](N)C([O-])=O FFRCYLXQILHVNV-BBDGQJMTSA-K 0.000 description 1
- BZOGNUBGXANBET-MDTVQASCSA-L cobalt(2+);(2s)-2,6-diaminohexanoate Chemical compound [Co+2].NCCCC[C@H](N)C([O-])=O.NCCCC[C@H](N)C([O-])=O BZOGNUBGXANBET-MDTVQASCSA-L 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 1
- VVYPIVJZLVJPGU-UHFFFAOYSA-L copper;2-aminoacetate Chemical compound [Cu+2].NCC([O-])=O.NCC([O-])=O VVYPIVJZLVJPGU-UHFFFAOYSA-L 0.000 description 1
- 238000002036 drum drying Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- AACACXATQSKRQG-UHFFFAOYSA-L magnesium;2-aminoacetate Chemical compound [Mg+2].NCC([O-])=O.NCC([O-])=O AACACXATQSKRQG-UHFFFAOYSA-L 0.000 description 1
- LBYCWLBCHNSWFE-UHFFFAOYSA-L magnesium;pyridine-3-carboxylate Chemical compound [Mg+2].[O-]C(=O)C1=CC=CN=C1.[O-]C(=O)C1=CC=CN=C1 LBYCWLBCHNSWFE-UHFFFAOYSA-L 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 150000002814 niacins Chemical class 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- NJNDBGREJCHIFG-MDTVQASCSA-L zinc;(2s)-2,6-diaminohexanoate Chemical compound [Zn+2].NCCCC[C@H](N)C([O-])=O.NCCCC[C@H](N)C([O-])=O NJNDBGREJCHIFG-MDTVQASCSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/06—Cobalt compounds
- C07F15/065—Cobalt compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F11/00—Compounds containing elements of Groups 6 or 16 of the Periodic Table
- C07F11/005—Compounds containing elements of Groups 6 or 16 of the Periodic Table compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
- C07F13/005—Compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage
Definitions
- the present invention eliminates the disadvantages associated with producing organic acid chelates in an initial aqueous environment and describes a method for producing metal organic acid chelates in a substantially non-water media.
- the metal organic acid chelate product when allowed to dry, has the physical characteristic of a very fine powder, which does not require subsequent milling.
- salts, complexes and chelates of Ca, Mg, Mn, Cu, Zn, Co, Cr, K, Fe and other metals of interest can be mixed with appropriate amounts of citric acid, ascorbic acid, picolinic acid, nicotinic acid, glycine, lysine, glutamic or other organic acids, dipeptides, polypeptides and protein hydrolizates in a non-aqueous liquid such as methanol, i-propanol, hexane, or other non water organic liquid to obtain the desired chelate product which does not require milling subsequent to extraction from the suspension.
- a non-aqueous liquid such as methanol, i-propanol, hexane, or other non water organic liquid to obtain the desired chelate product which does not require milling subsequent to extraction from the suspension.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/261,610 US6670494B1 (en) | 2001-12-17 | 2002-09-30 | Method for preparation of metal organic acid chelates |
CA002447584A CA2447584A1 (en) | 2001-12-17 | 2003-10-31 | Preparation of metal organic acid chelates |
EP03257013A EP1529775B1 (de) | 2001-12-17 | 2003-11-06 | Verfahren zur Herstellung von Chelaten von Metallen mit organischen Säuren |
DE2003604713 DE60304713T2 (de) | 2003-11-06 | 2003-11-06 | Verfahren zur Herstellung von Chelaten von Metallen mit organischen Säuren |
AT03257013T ATE323670T1 (de) | 2003-11-06 | 2003-11-06 | Verfahren zur herstellung von chelaten von metallen mit organischen säuren |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33977701P | 2001-12-17 | 2001-12-17 | |
US10/261,610 US6670494B1 (en) | 2001-12-17 | 2002-09-30 | Method for preparation of metal organic acid chelates |
CA002447584A CA2447584A1 (en) | 2001-12-17 | 2003-10-31 | Preparation of metal organic acid chelates |
EP03257013A EP1529775B1 (de) | 2001-12-17 | 2003-11-06 | Verfahren zur Herstellung von Chelaten von Metallen mit organischen Säuren |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1529775A1 true EP1529775A1 (de) | 2005-05-11 |
EP1529775B1 EP1529775B1 (de) | 2006-04-19 |
Family
ID=34714416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03257013A Expired - Lifetime EP1529775B1 (de) | 2001-12-17 | 2003-11-06 | Verfahren zur Herstellung von Chelaten von Metallen mit organischen Säuren |
Country Status (3)
Country | Link |
---|---|
US (1) | US6670494B1 (de) |
EP (1) | EP1529775B1 (de) |
CA (1) | CA2447584A1 (de) |
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007017402A1 (en) * | 2005-08-05 | 2007-02-15 | Sicit Chemitech S.P.A. | Process for the production of hydrolyzed-protein based products in composition with manganese |
WO2007068753A1 (en) * | 2005-12-15 | 2007-06-21 | Sicit Chemitech S.P.A. | Process for the production of hydrolyzed-protein based products in composition with zinc |
EP2489670A1 (de) * | 2011-02-17 | 2012-08-22 | IS Forschungsgesellschaft mbH | Verfahren zur Herstellung von Aminosäure-Chelat-Verbindungen, Aminosäure-Chelat-Verbindungen und Verwendung von Aminosäure-Chelat-Verbindungen |
CN103739509A (zh) * | 2014-01-09 | 2014-04-23 | 山东祥维斯生物科技有限公司 | 一种甘氨酸螯合锰的工业化生产制备工艺 |
WO2014098818A1 (en) * | 2012-12-19 | 2014-06-26 | Colgate-Palmolive Company | Zinc-lysine complex |
CN105439880A (zh) * | 2016-01-25 | 2016-03-30 | 延边大学 | 一种甘氨酸钙的制备方法 |
US9498421B2 (en) | 2012-12-19 | 2016-11-22 | Colgate-Palmolive Company | Two component compositions containing tetrabasic zinc-amino acid halide complexes and cysteine |
US9504858B2 (en) | 2012-12-19 | 2016-11-29 | Colgate-Palmolive Company | Zinc amino acid halide complex with cysteine |
CN106414460A (zh) * | 2014-06-18 | 2017-02-15 | 高露洁-棕榄公司 | 从氯化锌合成锌‑赖氨酸络合物 |
US9572756B2 (en) | 2012-12-19 | 2017-02-21 | Colgate-Palmolive Company | Teeth whitening methods, visually perceptible signals and compositions therefor |
CN106459094A (zh) * | 2014-06-18 | 2017-02-22 | 高露洁-棕榄公司 | 锌‑赖氨酸络合物的低pH合成 |
CN106478438A (zh) * | 2016-09-26 | 2017-03-08 | 河北东华冀衡化工有限公司 | 一种甘氨酸镁螯合物的制备方法 |
US9675823B2 (en) | 2012-12-19 | 2017-06-13 | Colgate-Palmolive Company | Two component compositions containing zinc amino acid halide complexes and cysteine |
US9750670B2 (en) | 2012-12-19 | 2017-09-05 | Colgate-Palmolive Company | Zinc amino acid complex with cysteine |
US9763865B2 (en) | 2012-12-19 | 2017-09-19 | Colgate-Palmolive Company | Oral gel comprising zinc-amino acid complex |
US9775792B2 (en) | 2012-12-19 | 2017-10-03 | Colgate-Palmolive Company | Oral care products comprising a tetrabasic zinc-amino acid-halide complex |
US9827177B2 (en) | 2012-12-19 | 2017-11-28 | Colgate-Palmolive Company | Antiperspirant products with protein and antiperspirant salts |
US9861563B2 (en) | 2012-12-19 | 2018-01-09 | Colgate-Palmolive Company | Oral care products comprising tetrabasic zinc chloride and trimethylglycine |
US9901523B2 (en) | 2012-12-19 | 2018-02-27 | Colgate-Palmolive Company | Oral care products comprising zinc oxide and trimethylglycine |
US9925130B2 (en) | 2012-12-19 | 2018-03-27 | Colgate-Palmolive Company | Composition with zinc amino acid/trimethylglycine halide precursors |
US9943473B2 (en) | 2012-12-19 | 2018-04-17 | Colgate-Palmolive Company | Zinc lysine halide complex |
US9980890B2 (en) | 2012-12-19 | 2018-05-29 | Colgate-Palmolive Company | Zinc amino acid halide mouthwashes |
US10105303B2 (en) | 2012-12-19 | 2018-10-23 | Colgate-Palmolive Company | Oral care composition comprising zinc amino acid halides |
CN109180510A (zh) * | 2018-08-29 | 2019-01-11 | 长沙兴嘉生物工程股份有限公司 | 一种高纯谷氨酸亚铁的制备方法 |
EP3670494A1 (de) * | 2018-12-18 | 2020-06-24 | Phytobiotics Futterzusatzstoffe GmbH | Herstellung einer lysinat-verbindung aus einer wässrigen lysinlösung |
US10952943B2 (en) | 2018-12-21 | 2021-03-23 | Colgate-Palmolive Company | Zinc-arginine-chloride complex |
US11091502B2 (en) | 2018-12-21 | 2021-08-17 | Colgate-Palmolive Company | Methods for synthesizing zinc-lysine-chloride complex |
US11117906B2 (en) | 2018-12-21 | 2021-09-14 | Colgate-Palmolive Company | Methods for synthesizing zinc-lysine-chloride complex |
US11229591B2 (en) | 2018-12-21 | 2022-01-25 | Colgate-Palmolive Company | Methods for synthesizing zinc-lysine-chloride complex |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW585320U (en) * | 2001-08-17 | 2004-04-21 | Tatung Co | Read control device of four-wire resistor type touch panel |
US6670494B1 (en) * | 2001-12-17 | 2003-12-30 | J H Brotech, Inc. | Method for preparation of metal organic acid chelates |
US6992203B2 (en) * | 2002-03-26 | 2006-01-31 | Jh Biotech, Inc. | Metal complexes produced by Maillard Reaction products |
ES2659236T3 (es) * | 2004-06-07 | 2018-03-14 | Syngenta Participations Ag | Métodos de reducción del daño por nematodos |
KR100481326B1 (ko) * | 2004-06-22 | 2005-04-07 | 주식회사 동암비티 | 유기태 킬레이트의 제조방법 |
US7495117B2 (en) * | 2006-08-04 | 2009-02-24 | Kemin Industries, Inc. | Metal carboxylate salts |
CN103626669A (zh) * | 2013-12-13 | 2014-03-12 | 四川生科力科技有限公司 | 甘氨酸镁螯合物的制备方法 |
CN106278916B (zh) * | 2016-09-05 | 2018-04-13 | 河北东华冀衡化工有限公司 | 一种甘氨酸铜的制备方法 |
KR102068016B1 (ko) * | 2017-07-14 | 2020-01-21 | 씨제이제일제당 주식회사 | 메티오닌-금속 킬레이트 및 이의 제조방법 |
RU2654464C1 (ru) * | 2017-12-27 | 2018-05-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный университет" (ФГБОУ ВО "КубГУ") | Способ получения координационного соединения меди(II) с пиколиновой кислотой |
WO2020243674A1 (en) | 2019-05-30 | 2020-12-03 | Compass Minerals Usa Inc. | Micronutrient foliar solutions |
CN111663151B (zh) * | 2020-04-24 | 2021-08-31 | 广西科学院 | 一种电化学-络合反应技术制备高纯甘氨酸钙的工艺 |
US20210369768A1 (en) * | 2020-06-01 | 2021-12-02 | Balchem Corporation | Metal di-amino acid chelates or metal tri-amino acid chelates |
CN112624933A (zh) * | 2020-12-31 | 2021-04-09 | 河北力维素科技有限公司 | 一种支链氨基酸螯合铜的制备方法 |
CN113735729A (zh) * | 2021-08-03 | 2021-12-03 | 四川吉隆达生物科技集团有限公司 | 饲料级谷氨酸亚铁的生产工艺 |
CN113845435A (zh) * | 2021-10-14 | 2021-12-28 | 四川吉隆达生物科技集团有限公司 | 饲料级谷氨酸锰的生产工艺 |
CN115073525A (zh) * | 2022-05-12 | 2022-09-20 | 昕嘉生物技术(长沙)有限公司 | 一种甜菜碱硫酸锰晶体的制备方法及其产品 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0471583A1 (de) * | 1990-08-16 | 1992-02-19 | Hampshire Chemical Corporation | Verfahren zur Herstellung von Salzen von Eisenkomplexen von Amino- und Hydroxycarbonsäuren |
US6197815B1 (en) * | 1998-03-18 | 2001-03-06 | J.H. Biotech, Inc. | Amino acid chelates to reduce still births and increase birth weight in non-human animals |
US6469169B1 (en) * | 2001-03-20 | 2002-10-22 | Council Of Scientific And Industrial Research | Water soluble palladium complexes and process for the preparation thereof |
US6670494B1 (en) * | 2001-12-17 | 2003-12-30 | J H Brotech, Inc. | Method for preparation of metal organic acid chelates |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4216143A (en) * | 1977-10-20 | 1980-08-05 | Ashmead H H | Soluble non-ferrous metal proteinates |
US4315927A (en) | 1980-08-08 | 1982-02-16 | The United States Of America As Represented By The Secretary Of Agriculture | Dietary supplementation with essential metal picolinates |
US4599152A (en) | 1985-05-24 | 1986-07-08 | Albion Laboratories | Pure amino acid chelates |
US4814177A (en) | 1986-03-18 | 1989-03-21 | Board Of Regents, University Of Texas System | Ultradense and more soluble and bioavailable preparations of calcium citrate |
US4830716B1 (en) | 1986-07-03 | 1999-12-07 | Albion Int | Preparation of pharmaceutical grade amino acid chelates |
US5504055A (en) | 1994-03-15 | 1996-04-02 | J.H. Biotech, Inc. | Metal amino acid chelate |
US5516925A (en) | 1994-08-23 | 1996-05-14 | Albion International, Inc. | Amino acid chelates having improved palatability |
US6294207B1 (en) * | 1999-11-01 | 2001-09-25 | Albion International, Inc. | Calcium fortification of oleaginous foods |
US6166071A (en) * | 2000-03-13 | 2000-12-26 | Albion International, Inc. | Zinc amino acid chelates having ligands comprised of glycine and a sulfur-containing amino acids |
US6518240B1 (en) * | 2000-10-11 | 2003-02-11 | Albion International, Inc. | Composition and method for preparing amino acid chelates and complexes |
US6407138B1 (en) * | 2000-10-11 | 2002-06-18 | Albion International, Inc. | Composition and method for preparing electrically neutral amino acid chelates free of interfering ions |
-
2002
- 2002-09-30 US US10/261,610 patent/US6670494B1/en not_active Expired - Lifetime
-
2003
- 2003-10-31 CA CA002447584A patent/CA2447584A1/en not_active Abandoned
- 2003-11-06 EP EP03257013A patent/EP1529775B1/de not_active Expired - Lifetime
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0471583A1 (de) * | 1990-08-16 | 1992-02-19 | Hampshire Chemical Corporation | Verfahren zur Herstellung von Salzen von Eisenkomplexen von Amino- und Hydroxycarbonsäuren |
US6197815B1 (en) * | 1998-03-18 | 2001-03-06 | J.H. Biotech, Inc. | Amino acid chelates to reduce still births and increase birth weight in non-human animals |
US6469169B1 (en) * | 2001-03-20 | 2002-10-22 | Council Of Scientific And Industrial Research | Water soluble palladium complexes and process for the preparation thereof |
US6670494B1 (en) * | 2001-12-17 | 2003-12-30 | J H Brotech, Inc. | Method for preparation of metal organic acid chelates |
Cited By (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007017402A1 (en) * | 2005-08-05 | 2007-02-15 | Sicit Chemitech S.P.A. | Process for the production of hydrolyzed-protein based products in composition with manganese |
WO2007068753A1 (en) * | 2005-12-15 | 2007-06-21 | Sicit Chemitech S.P.A. | Process for the production of hydrolyzed-protein based products in composition with zinc |
RU2567057C2 (ru) * | 2011-02-17 | 2015-10-27 | ИСФ ГмбХ | Способ получения аминокислотных хелатных соединений, аминокислотные хелатные соединения и применение аминокислотных хелатных соединений |
EP2489670A1 (de) * | 2011-02-17 | 2012-08-22 | IS Forschungsgesellschaft mbH | Verfahren zur Herstellung von Aminosäure-Chelat-Verbindungen, Aminosäure-Chelat-Verbindungen und Verwendung von Aminosäure-Chelat-Verbindungen |
WO2012110063A1 (de) * | 2011-02-17 | 2012-08-23 | Isf Gmbh | Verfahren zur herstellung von aminosäure-chelat-verbindungen, aminosäure-chelat-verbindungen und verwendung von aminosäure-chelat-verbindungen |
CN103492394A (zh) * | 2011-02-17 | 2014-01-01 | Isf有限公司 | 用于制备氨基酸螯合物的方法,氨基酸螯合物和氨基酸螯合物的用途 |
US20140037960A1 (en) * | 2011-02-17 | 2014-02-06 | Isf Gmbh | Method for Producing Amino Acid Chelate Compounds, Amino Acid Chelate Compounds and Use of Amino Acid Chelate Compounds |
CN103492394B (zh) * | 2011-02-17 | 2016-06-01 | Isf有限公司 | 用于制备氨基酸螯合物的方法,氨基酸螯合物和氨基酸螯合物的用途 |
US9346830B2 (en) | 2011-02-17 | 2016-05-24 | Isf Ag | Method for producing amino acid chelate compounds, amino acid chelate compounds and use of amino acid chelate compounds |
US9827177B2 (en) | 2012-12-19 | 2017-11-28 | Colgate-Palmolive Company | Antiperspirant products with protein and antiperspirant salts |
US9980890B2 (en) | 2012-12-19 | 2018-05-29 | Colgate-Palmolive Company | Zinc amino acid halide mouthwashes |
US11197811B2 (en) | 2012-12-19 | 2021-12-14 | Colgate-Palmolive Company | Teeth whitening methods, visually perceptible signals and compositions therefor |
CN104854114A (zh) * | 2012-12-19 | 2015-08-19 | 高露洁-棕榄公司 | 锌-赖氨酸络合物 |
WO2014098818A1 (en) * | 2012-12-19 | 2014-06-26 | Colgate-Palmolive Company | Zinc-lysine complex |
US9498421B2 (en) | 2012-12-19 | 2016-11-22 | Colgate-Palmolive Company | Two component compositions containing tetrabasic zinc-amino acid halide complexes and cysteine |
US9504858B2 (en) | 2012-12-19 | 2016-11-29 | Colgate-Palmolive Company | Zinc amino acid halide complex with cysteine |
US10792236B2 (en) | 2012-12-19 | 2020-10-06 | Colgate-Palmolive Company | Dentifrice comprising zinc-amino acid complex |
US9572756B2 (en) | 2012-12-19 | 2017-02-21 | Colgate-Palmolive Company | Teeth whitening methods, visually perceptible signals and compositions therefor |
US10610475B2 (en) | 2012-12-19 | 2020-04-07 | Colgate-Palmolive Company | Teeth whitening methods, visually perceptible signals and compositions therefor |
US10610470B2 (en) | 2012-12-19 | 2020-04-07 | Colgate-Palmolive Company | Oral care composition zinc-lysine complex |
RU2615131C2 (ru) * | 2012-12-19 | 2017-04-04 | Колгейт-Палмолив Компани | Цинк-лизиновый комплекс |
US9675823B2 (en) | 2012-12-19 | 2017-06-13 | Colgate-Palmolive Company | Two component compositions containing zinc amino acid halide complexes and cysteine |
US9750670B2 (en) | 2012-12-19 | 2017-09-05 | Colgate-Palmolive Company | Zinc amino acid complex with cysteine |
US9757316B2 (en) | 2012-12-19 | 2017-09-12 | Colgate-Palmolive Company | Zinc-lysine complex |
US9763865B2 (en) | 2012-12-19 | 2017-09-19 | Colgate-Palmolive Company | Oral gel comprising zinc-amino acid complex |
US9775792B2 (en) | 2012-12-19 | 2017-10-03 | Colgate-Palmolive Company | Oral care products comprising a tetrabasic zinc-amino acid-halide complex |
US10588841B2 (en) | 2012-12-19 | 2020-03-17 | Colgate-Palmolive Company | Oral care compositions comprising zinc amino acid halides |
US9861563B2 (en) | 2012-12-19 | 2018-01-09 | Colgate-Palmolive Company | Oral care products comprising tetrabasic zinc chloride and trimethylglycine |
US9901523B2 (en) | 2012-12-19 | 2018-02-27 | Colgate-Palmolive Company | Oral care products comprising zinc oxide and trimethylglycine |
US9925130B2 (en) | 2012-12-19 | 2018-03-27 | Colgate-Palmolive Company | Composition with zinc amino acid/trimethylglycine halide precursors |
US9943473B2 (en) | 2012-12-19 | 2018-04-17 | Colgate-Palmolive Company | Zinc lysine halide complex |
CN104854114B (zh) * | 2012-12-19 | 2018-05-08 | 高露洁-棕榄公司 | 锌-赖氨酸络合物 |
US10524995B2 (en) | 2012-12-19 | 2020-01-07 | Colgate-Palmolive Company | Zinc amino acid halide mouthwashes |
US10105303B2 (en) | 2012-12-19 | 2018-10-23 | Colgate-Palmolive Company | Oral care composition comprising zinc amino acid halides |
US10245222B2 (en) | 2012-12-19 | 2019-04-02 | Colgate-Palmolive Company | Dentifrice comprising zinc-amino acid complex |
US10195125B2 (en) | 2012-12-19 | 2019-02-05 | Colgate-Palmolive Company | Oral care composition comprising zinc-lysine complex |
CN103739509B (zh) * | 2014-01-09 | 2015-12-30 | 山东祥维斯生物科技股份有限公司 | 一种甘氨酸螯合锰的工业化生产制备工艺 |
CN103739509A (zh) * | 2014-01-09 | 2014-04-23 | 山东祥维斯生物科技有限公司 | 一种甘氨酸螯合锰的工业化生产制备工艺 |
CN106414460A (zh) * | 2014-06-18 | 2017-02-15 | 高露洁-棕榄公司 | 从氯化锌合成锌‑赖氨酸络合物 |
CN106459094B (zh) * | 2014-06-18 | 2019-07-16 | 高露洁-棕榄公司 | 锌-赖氨酸络合物的低pH合成 |
CN106414460B (zh) * | 2014-06-18 | 2019-07-16 | 高露洁-棕榄公司 | 从氯化锌合成锌-赖氨酸络合物 |
CN106459094A (zh) * | 2014-06-18 | 2017-02-22 | 高露洁-棕榄公司 | 锌‑赖氨酸络合物的低pH合成 |
CN105439880A (zh) * | 2016-01-25 | 2016-03-30 | 延边大学 | 一种甘氨酸钙的制备方法 |
CN106478438A (zh) * | 2016-09-26 | 2017-03-08 | 河北东华冀衡化工有限公司 | 一种甘氨酸镁螯合物的制备方法 |
CN109180510B (zh) * | 2018-08-29 | 2021-08-24 | 长沙兴嘉生物工程股份有限公司 | 一种高纯谷氨酸亚铁的制备方法 |
CN109180510A (zh) * | 2018-08-29 | 2019-01-11 | 长沙兴嘉生物工程股份有限公司 | 一种高纯谷氨酸亚铁的制备方法 |
WO2020126647A1 (de) * | 2018-12-18 | 2020-06-25 | Phytobiotics Futterzusatzstoffe Gmbh | Herstellung einer lysinat-verbindung aus einer wässrigen lysinlösung |
CN113316565A (zh) * | 2018-12-18 | 2021-08-27 | 惠托斯饲料添加剂股份有限公司 | 由赖氨酸水溶液制备单赖氨酸盐化合物 |
EP3670494A1 (de) * | 2018-12-18 | 2020-06-24 | Phytobiotics Futterzusatzstoffe GmbH | Herstellung einer lysinat-verbindung aus einer wässrigen lysinlösung |
US10952943B2 (en) | 2018-12-21 | 2021-03-23 | Colgate-Palmolive Company | Zinc-arginine-chloride complex |
US11091502B2 (en) | 2018-12-21 | 2021-08-17 | Colgate-Palmolive Company | Methods for synthesizing zinc-lysine-chloride complex |
US11117906B2 (en) | 2018-12-21 | 2021-09-14 | Colgate-Palmolive Company | Methods for synthesizing zinc-lysine-chloride complex |
US11229591B2 (en) | 2018-12-21 | 2022-01-25 | Colgate-Palmolive Company | Methods for synthesizing zinc-lysine-chloride complex |
US11826448B2 (en) | 2018-12-21 | 2023-11-28 | Colgate-Palmolive Company | Zinc-arginine-chloride complex |
Also Published As
Publication number | Publication date |
---|---|
CA2447584A1 (en) | 2005-04-30 |
EP1529775B1 (de) | 2006-04-19 |
US6670494B1 (en) | 2003-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1529775B1 (de) | Verfahren zur Herstellung von Chelaten von Metallen mit organischen Säuren | |
US5504055A (en) | Metal amino acid chelate | |
US6992203B2 (en) | Metal complexes produced by Maillard Reaction products | |
US5516925A (en) | Amino acid chelates having improved palatability | |
US6710079B1 (en) | Composition and method for preparing amino acid chelates and complexes free of interfering complex ions | |
DE2648971C2 (de) | ||
KR100282109B1 (ko) | 동물사료보충물로서사용되는금속카복실레이트의촉매화제조방법 | |
Köse et al. | Synthesis and characterization of bis (N, N-diethylnicotinamide) m-hydroxybenzoate complexes of Co (II), Ni (H), Cu (II), and Zn (II) | |
AU2003261466B2 (en) | Method for Preparation of Metal Organic Acid Chelates | |
JP4252882B2 (ja) | 金属有機酸キレートの製造方法 | |
EP1266901B1 (de) | Herstellung von Metallkomplexen von Aminosäuren, hergestellt durch Hydrolyse von Sojaprotein | |
RU2582680C1 (ru) | КОМПЛЕКСОНАТЫ ЭТИЛЕНДИАМИН-β-ПРОПИОНОВЫХ КИСЛОТ С ДВУХВАЛЕНТНЫМИ МЕТАЛЛАМИ: МЕДЬЮ, ЦИНКОМ, НИКЕЛЕМ И КОБАЛЬТОМ, И СПОСОБЫ ИХ ПОЛУЧЕНИЯ | |
US20080033196A1 (en) | Metal carboxylate salts | |
US20050235718A1 (en) | Organic amino acid chelates, methods for making such chelates, and methods for using such chelates | |
EP3653633B1 (de) | Methionin-metall-chelat und herstellungsverfahren dafür | |
JP2002047266A (ja) | メチオニン・遷移金属錯体およびアミノ酸を含む組成物 | |
CN108456016A (zh) | 一种水溶性有机钛肥及其制备方法 | |
US6486318B1 (en) | Single pot process for preparing metal picolinates from alpha picoline | |
CN111990542A (zh) | 甘氨酸络合物锌盐预混料的制备方法及其生产系统 | |
Pérez et al. | Isostructural cobalt (II) and zinc (II) complexes of the N, N-bis (carboxymethyl)-β-alaninato (3−) ion. Crystal structure of the cobalt (II) derivative,[Co (H2O) 6][Co2L2 (H2O) 2]· 4H2O | |
KR20000053858A (ko) | 금속 킬레이트의 제조방법 및 이를 함유하는 가축용 사료 | |
KR0184380B1 (ko) | 피콜린산크롬의 제조방법 | |
KR100581743B1 (ko) | 동물 사료로 사용하기 위한 2-히드록시-4-메틸티오부탄산의 금속 착물 | |
DE10352129A1 (de) | Verfahren zur Herstellung einer Organozinkverbindung und deren Verwendung in einer zinkhaltigen Zusammensetzung für die Nahrungsergänzung | |
US7405313B2 (en) | Method for the synthesis of basic chromium carboxylates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
17P | Request for examination filed |
Effective date: 20050722 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
AKX | Designation fees paid |
Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060419 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060419 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20060419 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060419 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060419 Ref country code: CH Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060419 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060419 Ref country code: LI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060419 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060419 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060419 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 60304713 Country of ref document: DE Date of ref document: 20060524 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060719 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060719 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060730 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060919 |
|
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20061106 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20061130 |
|
ET | Fr: translation filed | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20070122 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20070731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20061130 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060720 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060719 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060419 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20061020 Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060419 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20061106 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060419 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20221128 Year of fee payment: 20 Ref country code: DE Payment date: 20221125 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20221128 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 60304713 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20231105 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MK Effective date: 20231106 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20231105 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20231105 |